You can help our author matching system! If you notice any publications incorrectly attributed to this author, please
sign in and mark matches as correct or incorrect.
|
St Clair-Glover M, Yousuf A, Kaul D, et al. (2025) GABA Receptor Modulation of Membrane Excitability in Human Pluripotent Stem Cell-Derived Sensory Neurons by Baclofen and α-Conotoxin Vc1.1. Journal of Neurochemistry. 169: e70004 |
Tae HS, Hung A, Clark RJ, et al. (2024) Molecular determinants of the selectivity and potency of α-conotoxin Vc1.1 for human nicotinic acetylcholine receptors. The Journal of Biological Chemistry. 108017 |
Li T, Tae HS, Chen S, et al. (2024) Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain. Journal of Medicinal Chemistry |
Li X, Zhou S, Tae HS, et al. (2024) N-Terminal Capping of the αO-Conotoxin Analogue GeX-2 Improves the Serum Stability and Selectivity toward the Human α9α10 Nicotinic Acetylcholine Receptor. Journal of Medicinal Chemistry |
Tae HS, Ortells MO, Yousuf A, et al. (2024) Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA receptor and Ca2.2 channel. Biochemical Pharmacology. 116183 |
Li T, Tae HS, Liang J, et al. (2024) Rational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors. Marine Drugs. 22 |
Li X, Tae HS, Chen S, et al. (2024) Dual Antagonism of α9α10 nAChR and GABA Receptor-Coupled Ca2.2 Channels by an Analgesic αO-Conotoxin Analogue. Journal of Medicinal Chemistry |
Hackney CM, Flórez Salcedo P, Mueller E, et al. (2023) A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3. Plos Biology. 21: e3002217 |
Finol-Urdaneta RK, Zhorov BS, Baden DG, et al. (2023) Brevetoxin versus Brevenal Modulation of Human Nav1 Channels. Marine Drugs. 21 |
Tae HS, Ortells MO, Tekarli BJ, et al. (2023) DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms. Acs Chemical Neuroscience |